Literature DB >> 9568148

Fine needle aspiration cytology of glycogen-rich clear cell carcinoma of the breast. A case report.

F Satoh1, S Umemura, H Itoh, Y Miyajima, Y Tokuda, T Tajima, R Y Osamura.   

Abstract

BACKGROUND: Glycogen-rich clear cell carcinoma (GRCC) is a rare variant of breast carcinoma that was first described by Hull et al in 1981. The histologic findings have been described; however, the cytologic characteristics have not been well described. CASE: A 44-year-old female exhibited a palpable mass in her right breast. The fine needle aspirate contained cell clusters in a necrotic background. In addition to carcinoma cells with increased degrees of nuclear atypia, carcinoma cells with less atypia were identified. The tumor cells contained small round or ovoid nuclei and abundant, clear cytoplasm. The tumor, resected by modified radical mastectomy, was diagnosed as GRCC with detection of glycogen accumulation in the cytoplasm.
CONCLUSION: Although rare, glycogen-rich clear cell carcinoma should be considered in the differential diagnosis of breast cancer in fine needle aspiration cytology to prevent misdiagnosis because of its varied morphologic patterns and less atypical cytologic features.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568148     DOI: 10.1159/000331629

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  2 in total

1.  Glycogen-rich clear cell carcinoma of the breast: a case report.

Authors:  Yuji Mizukami; Teruhiko Takayama; Akihiro Takemura; Katsuhiro Ichikawa; Masahisa Onoguchi; Takao Taniya
Journal:  J Med Ultrason (2001)       Date:  2009-03-14       Impact factor: 1.314

2.  Glycogen-rich clear cell carcinoma of the breast with solid papillary pattern: Two cases with heterogeneous clinicopathological features.

Authors:  Tiberiu-Augustin Georgescu; Octavian Munteanu; Antonia-Carmen Lisievici; Tiberiu Tebeică; Dragoș Crețoiu; Oana Toader; Nicolae Suciu; Roxana Elena Bohîlțea
Journal:  Exp Ther Med       Date:  2021-03-22       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.